Mr McPherson joined Patrys in October 2008 having had over 10 years’ experience in the biotechnology and pharmaceutical industry. During this time he spent four years as CFO and Company Secretary at Cerylid Biosciences Limited, where he provided strategic direction and information reporting and support for research and development activities, and a total of six years at Amrad Corporation Ltd in a number of senior finance roles.
During his career, Mr McPherson has accumulated more than 20 years’ experience in senior finance roles spanning a number of industries. Most recently, he was CFO and Company Secretary at eChoice Home Loans where he was responsible for financial affairs and corporate administration.
Mr John Read, Chairman of Patrys thanked Mr Hollingsworth on behalf of the Board for his valued contribution.
About Patrys Limited
Based in Melbourne, Australia, Patrys (ASX: PAB) is focused on the commercialisation of its proprietary platform technologies for the capture, production, and development of natural human antibodies as therapies for cancer and other major diseases. Patrys has a deep pipeline of anti-cancer natural human antibodies, two of which are scheduled to enter human clinical trials starting in 2009. In addition to its internal programs, Patrys has collaborations with several larger pharmaceutical companies to advance additional anti-cancer products from its pipeline. For further information about Patrys, please refer to www.patrys.com.
